Aclaris Therapeutics (ACRS) Reports Q4 Loss of $0.28/Share

Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 EPS of ($0.28), versus ($1.76) reported last year.

For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen
• Six Flags names Mark Pauls as chief operating officer